Trial intelligence / Profile preview

CHOICE: Intraarterial Alteplase in Acute Stroke

NCT03876119Phase 3Completed

Sponsor
Hospital Clínic de Barcelona
Start
Dec 2018
Primary completion
May 2021
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Hospital Clínic de Barcelona. Started Dec 2018; status: completed.

02

Drugs

tissue-plasminogen activator
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT03876119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03876119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call